Soricimed Biopharma Inc.

Dedicated to developing effective and novel targeted treatments for cancer.

[Soricimed Biopharma Inc. @Soricimed]

Soricimed is focused on developing effective, highly-targeted therapeutics for several solid tumor cancers, like pancreatic cancer, with the goal of one day making an impact on those living with this disease.

[Soricimed Biopharma Inc. @Soricimed]

According to the Canadian Cancer Society, just under 7,000 Canadians were diagnosed with pancreatic cancer last year, with roughly 5,700 patients succumbing to the disease.

[Soricimed Biopharma Inc. @Soricimed]

Today we are celebrating #InternationalWomensDay. We're proud of the female leaders we work with in the healthcare industry and beyond. They are always managing different aspects of their lives and inspiring us to do the same. Today, and every day, we celebrate them.

[Soricimed Biopharma Inc. @Soricimed]

Today is #RareDiseaseDay, a day to raise awareness of the over 7,000 rare diseases that impact over 300M people globally. Each of us can make a difference in the lives of those affected by rare diseases. Rare is Many, Rare is Strong, Rare is Proud! 
@rarediseaseday

[Soricimed Biopharma Inc. @Soricimed]

Today we recognize #ICCD2023 to raise awareness about childhood cancer, and to express support and understanding for children and adolescents living with the disease, survivors and their families. @IntChildCancer #ThroughTheirHands #CUREALL

[Soricimed Biopharma Inc. @Soricimed]

Targeted cancer therapy is a type of precision cancer treatment that uses drugs designed to “target” cancer cells. This method of delivery can: 
▪️ Less harmful to healthy cells 
▪️ Fewer systemic side effects
▪️ Potential for better efficacy 
More: https://t.co/Tpzh8iVGuC

[Soricimed Biopharma Inc. @Soricimed]

This #WorldCancerDay, and every day, we are committed to improving the lives of those impacted by cancer. This year's theme is #CloseTheCareGap, and we encourage you to advocate for awareness, conversation, and changes in equity in access to cancer care. https://t.co/F5kS51ddGb

[Soricimed Biopharma Inc. @Soricimed]

Cancer currently impacts 1.5 million Canadians but investments in research, methods of detection and more effective treatments are helping people live longer with and after the disease.

Learn more in @cancersociety's 2022 special report: https://t.co/vnS2uAjzPq

[Soricimed Biopharma Inc. @Soricimed]

Soricimed’s targeting platform is showing potential as a treatment for solid tumor cancers, including pancreatic cancer. We will continue our tireless efforts to hopefully one day see our technology used to benefit Canadians living with this challenging form of cancer.

[Soricimed Biopharma Inc. @Soricimed]

Pancreatic Cancer is the toughest cancer to diagnose, treat and survive. Its survival rate is one of the lowest of common cancers, with a mortality rate of 90%.

[Soricimed Biopharma Inc. @Soricimed]

Most people diagnosed with pancreatic cancer are no longer alive five years after diagnosis. Today, we recognize #WorldPancreaticCancerDay. It's imperative to raise awareness of the symptoms and risk factors for this disease so it can be diagnosed quicker.

[Soricimed Biopharma Inc. @Soricimed]

#LungCancer is the leading cause of cancer death worldwide, accounting for about 1.8 million deaths each year. As with any form of cancer, early detection is key to survival. To learn more and support the fight against lung cancer visit https://t.co/CDsgYJs3Ay
@lungcancer_can

[Soricimed Biopharma Inc. @Soricimed]

At the #LifeSciencesInvestorDay hosted by @TMXGroup on Oct. 25, @RobertBruceCEO presented our innovation & discovery on treatments for several solid tumor cancers, alongside incredible life sciences & biotech companies from Canada. We are truly grateful for this opportunity!

[Soricimed Biopharma Inc. @Soricimed]

Interested in learning about our technology and ongoing developments in its potential as a cancer treatment? Join our mailing list for updates!
Visit: https://t.co/hqULrYEWVD

[Soricimed Biopharma Inc. @Soricimed]

Soricimed, like many other biopharma companies, is working hard to develop treatments for our country’s most common disease.

To learn more and find other recent stats about cancer in Canada, visit https://t.co/7xOHHRKWQO

[Soricimed Biopharma Inc. @Soricimed]

According to the recent Canadian Cancer Statistics publication, it’s estimated that there are over 233K new cancer cases and over 85K cancer deaths expected in Canada in 2022.

[Soricimed Biopharma Inc. @Soricimed]

#Breastcancerawarenessmonth
This month, let’s empower women living with breast cancer, encourage early detection & self-examination and make contributions to support ongoing research on the disease.
Learn more at https://t.co/BXJ1XrJLS2 @BreastCancerCDN

[Soricimed Biopharma Inc. @Soricimed]

Our peptide-receptor radionuclide therapy delivers radioisotopes to tumors with precision, rather than delivering a cytotoxic payload – this minimizes the damage to nearby healthy cells.

Learn more: https://t.co/LuHDE1r3Ah
@ISED_CA

[Soricimed Biopharma Inc. @Soricimed]

September is Prostate Cancer Awareness Month. Did you know that prostate cancer is the most commonly diagnosed cancer and the third leading cause of cancer death among men in Canada? Find out more and donate today at https://t.co/1T7h2LabQk

#ProstateCancer @cancersociety

[Soricimed Biopharma Inc. @Soricimed]

September is #OvarianCancerAwarenessMonth which seeks to raise awareness & support for this common disease in Canada. Knowing the signs & symptoms are key to early prevention. To learn more & support the fight against this cancer, visit: https://t.co/3lZ7KuBF9N
@OvarianCanada